Companies: 48,687 Total Market Cap: 127291036954077.85

Cencora

NYSE: COR
Healthcare Medical Distribution
Rank #357
Market Cap 56.65 B
Volume 1.05 M
Price 292.23
Change (%) 0.62%
Country or region United States United States

Cencora's latest marketcap:

56.65 B

As of May 4, 2025, Cencora's market capitalization has reached $56.65 B. According to our data, Cencora is the 357th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 56.65 B
Revenue (ttm) 303.19 B
Net Income (ttm) 1.40 B
Shares Out 193.92 M
EPS (ttm) 7.02
Forward PE 18.52
Ex-Dividend Date February 14, 2025
Earnings Date May 7, 2025
Market Cap Chart
Data Updated: May 4, 2025

Cencora's yearly market capitalization.

Cencora has seen its market value grow from $1.57 B to $55.80 B since 1998, representing a total increase of 3,443.06% and an annual compound growth rate (CAGR) of 14.51%.
Date Market Cap Change (%)
April 28, 2025 $55.80 B 28.49%
December 31, 2024 $43.43 B 5.35%
December 29, 2023 $41.22 B 20.95%
December 30, 2022 $34.08 B 23.22%
December 31, 2021 $27.66 B 38.52%
December 31, 2020 $19.97 B 14.05%
December 31, 2019 $17.51 B 11.03%
December 31, 2018 $15.77 B -21.26%
December 29, 2017 $20.02 B 16.36%
December 30, 2016 $17.21 B -19.3%
December 31, 2015 $21.33 B 8.16%
December 31, 2014 $19.72 B 21.91%
December 31, 2013 $16.17 B 59.07%
December 31, 2012 $10.17 B 5.83%
December 30, 2011 $9.61 B 1.9%
December 31, 2010 $9.43 B 25.55%
December 31, 2009 $7.51 B 34.82%
December 31, 2008 $5.57 B -26.08%
December 31, 2007 $7.54 B -12.74%
December 29, 2006 $8.64 B 0.04%
December 30, 2005 $8.63 B 39.95%
December 31, 2004 $6.17 B -2.03%
December 31, 2003 $6.30 B 8.4%
December 31, 2002 $5.81 B -11.9%
December 31, 2001 $6.59 B 149.72%
December 29, 2000 $2.64 B 238.52%
December 31, 1999 $779.90 M -50.48%
December 31, 1998 $1.57 B

Company Profile

About Cencora, Inc.

Cencora, Inc. is a global leader in pharmaceutical sourcing and distribution, operating in the United States and internationally. Formerly known as AmerisourceBergen Corporation, the company rebranded to Cencora, Inc. in August 2023.

Business Segments

U.S. Healthcare Solutions

  • Distributes pharmaceuticals, over-the-counter healthcare products, and home healthcare supplies to hospitals, pharmacies, clinics, and long-term care facilities.
  • Provides pharmacy management, staffing, consulting, and supply management software.
  • Offers packaging solutions, clinical trial support, and commercialization services for biotech and pharmaceutical manufacturers.
  • Supplies animal health products, including pharmaceuticals, vaccines, and diagnostics for companion and production animals.
  • Distributes plasma, blood products, injectables, and specialty pharmaceuticals to healthcare providers.

International Healthcare Solutions

  • Provides global pharmaceutical wholesale and commercialization services.
  • Distributes healthcare products to pharmacies, doctors, hospitals, and health centers.
  • Offers specialty transportation and logistics for the biopharmaceutical industry.

Company Background

Founded in 1871, Cencora, Inc. is headquartered in Conshohocken, Pennsylvania, and continues to play a pivotal role in the healthcare supply chain.

Frequently Asked Questions

As of May 4, 2025, Cencora (including the parent company, if applicable) has an estimated market capitalization of $56.65 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Cencora global market capitalization ranking is approximately 357 as of May 4, 2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region United States
Founded 2001
IPO Date n/a
Employees 46,000
CEO Robert Mauch
Sector Healthcare
Industry Medical Distribution
Address 1 West First Avenue
Conshohocken, Pennsylvania 19428-1800
United States